FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295185281> ?p ?o ?g. }

• W4295185281 endingPage "1408" @default.
• W4295185281 startingPage "1392" @default.
• W4295185281 abstract "Post-transplant lymphoproliferative disorder is a life-threatening complication of immunosuppression following transplantation mediated by failure of T cells to control Epstein-Barr virus (EBV)-infected and transformed B cells. Typically, a modification or reduction of immunosuppression is recommended, but insufficiently defined thus far. In order to help delineate this, we characterized EBV-antigen-specific T cells and lymphoblastoid cell lines from healthy donors and in patients with a kidney transplant in the absence or presence of the standard immunosuppressants tacrolimus, cyclosporin A, prednisolone, rapamycin, and mycophenolic acid. Phenotypes of lymphoblastoid cell-lines and T cells, T cell-receptor-repertoire diversity, and T-cell reactivity upon co-culture with autologous lymphoblastoid cell lines were analyzed. Rapamycin and mycophenolic acid inhibited lymphoblastoid cell-line proliferation. T cells treated with prednisolone and rapamycin showed nearly normal cytokine production. Proliferation and the viability of T cells were decreased by mycophenolic acid, while tacrolimus and cyclosporin A were strong suppressors of T-cell function including their killing activity. Overall, our study provides a basis for the clinical decision for the modification and reduction of immunosuppression and adds information to the complex balance of maintaining anti-viral immunity while preventing acute rejection. Thus, an immunosuppressive regime based on mTOR inhibition and reduced or withdrawn calcineurin inhibitors could be a promising strategy for patients with increased risk of or manifested EBV-associated post-transplant lymphoproliferative disorder." @default.
• W4295185281 created "2022-09-11" @default.
• W4295185281 creator A5011437185 @default.
• W4295185281 creator A5012871893 @default.
• W4295185281 creator A5016218153 @default.
• W4295185281 creator A5020854619 @default.
• W4295185281 creator A5033374084 @default.
• W4295185281 creator A5037283048 @default.
• W4295185281 creator A5046618146 @default.
• W4295185281 creator A5049295400 @default.
• W4295185281 creator A5053471997 @default.
• W4295185281 creator A5056678533 @default.
• W4295185281 creator A5059664524 @default.
• W4295185281 creator A5061694042 @default.
• W4295185281 creator A5063466900 @default.
• W4295185281 creator A5072736639 @default.
• W4295185281 creator A5073329269 @default.
• W4295185281 creator A5080601771 @default.
• W4295185281 creator A5089912303 @default.
• W4295185281 creator A5091199070 @default.
• W4295185281 date "2022-12-01" @default.
• W4295185281 modified "2023-10-18" @default.
• W4295185281 title "In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein–Barr virus–associated post-transplant lymphoproliferative disorder" @default.
• W4295185281 cites W1529424687 @default.
• W4295185281 cites W1531680230 @default.
• W4295185281 cites W1544215997 @default.
• W4295185281 cites W1544269146 @default.
• W4295185281 cites W1572743872 @default.
• W4295185281 cites W1598469594 @default.
• W4295185281 cites W1786008440 @default.
• W4295185281 cites W1883897672 @default.
• W4295185281 cites W1925602349 @default.
• W4295185281 cites W1965594537 @default.
• W4295185281 cites W196757896 @default.
• W4295185281 cites W1968505092 @default.
• W4295185281 cites W1971708446 @default.
• W4295185281 cites W1975401834 @default.
• W4295185281 cites W1979401674 @default.
• W4295185281 cites W1983100506 @default.
• W4295185281 cites W1984110560 @default.
• W4295185281 cites W1985278235 @default.
• W4295185281 cites W1988181926 @default.
• W4295185281 cites W1989632435 @default.
• W4295185281 cites W1993835819 @default.
• W4295185281 cites W1994080024 @default.
• W4295185281 cites W1994453026 @default.
• W4295185281 cites W1998407875 @default.
• W4295185281 cites W2011757232 @default.
• W4295185281 cites W2018832446 @default.
• W4295185281 cites W2019044913 @default.
• W4295185281 cites W2020254881 @default.
• W4295185281 cites W2022276421 @default.
• W4295185281 cites W2024382442 @default.
• W4295185281 cites W2027941603 @default.
• W4295185281 cites W2033725347 @default.
• W4295185281 cites W2034396448 @default.
• W4295185281 cites W2037926194 @default.
• W4295185281 cites W2041770150 @default.
• W4295185281 cites W2043857634 @default.
• W4295185281 cites W2044215074 @default.
• W4295185281 cites W2044812023 @default.
• W4295185281 cites W2047956224 @default.
• W4295185281 cites W2048737737 @default.
• W4295185281 cites W2060354653 @default.
• W4295185281 cites W2064380726 @default.
• W4295185281 cites W2064876347 @default.
• W4295185281 cites W2066738380 @default.
• W4295185281 cites W2072912951 @default.
• W4295185281 cites W2074502252 @default.
• W4295185281 cites W2088807765 @default.
• W4295185281 cites W2089845218 @default.
• W4295185281 cites W2091616383 @default.
• W4295185281 cites W2094352696 @default.
• W4295185281 cites W2095572685 @default.
• W4295185281 cites W2105998729 @default.
• W4295185281 cites W2114104545 @default.
• W4295185281 cites W2115042515 @default.
• W4295185281 cites W2116508491 @default.
• W4295185281 cites W2120823954 @default.
• W4295185281 cites W2122574217 @default.
• W4295185281 cites W2127115244 @default.
• W4295185281 cites W2128867940 @default.
• W4295185281 cites W2136169373 @default.
• W4295185281 cites W2137858837 @default.
• W4295185281 cites W2138234417 @default.
• W4295185281 cites W2138593912 @default.
• W4295185281 cites W2139718667 @default.
• W4295185281 cites W2142210684 @default.
• W4295185281 cites W2151139118 @default.
• W4295185281 cites W2151811858 @default.
• W4295185281 cites W2157620455 @default.
• W4295185281 cites W2160925670 @default.
• W4295185281 cites W2170235275 @default.
• W4295185281 cites W2170308172 @default.
• W4295185281 cites W2170955899 @default.
• W4295185281 cites W2262642897 @default.
• W4295185281 cites W2308250140 @default.
• W4295185281 cites W2331222889 @default.

• next